Autoimmune & Inflammatory Disorders

RyGen Biopharma develops biologic therapies designed to regulate immune system activity and reduce inflammation associated with autoimmune diseases. These therapies target key immune pathways responsible for chronic inflammatory conditions, helping improve disease management and patient quality of life.
Our development programs focus on innovative biologics that provide effective therapeutic options for patients suffering from immune-mediated disorders. Through advanced recombinant DNA technology and strong scientific expertise, RyGen aims to deliver safe, high-quality biologic treatments aligned with global regulatory standards.